The estimated Net Worth of William Walmsley Hall is at least $257 mil dollars as of 15 June 2020. Mr. Hall owns over 5,000 units of Evofem Biosciences Inc stock worth over $45 and over the last 7 years he sold EVFM stock worth over $0. In addition, he makes $257,400 as Independent Director at Evofem Biosciences Inc.
William has made over 1 trades of the Evofem Biosciences Inc stock since 2020, according to the Form 4 filled with the SEC. Most recently he bought 5,000 units of EVFM stock worth $14,250 on 15 June 2020.
The largest trade he's ever made was buying 5,000 units of Evofem Biosciences Inc stock on 15 June 2020 worth over $14,250. On average, William trades about 833 units every 0 days since 2018. As of 15 June 2020 he still owns at least 5,000 units of Evofem Biosciences Inc stock.
You can see the complete history of Mr. Hall stock trades at the bottom of the page.
William Hall M.D. Ph.D. serves as Independent Director of the Company. He currently serves as Distinguished Professor in Hokkaido University in Japan and is Professor Emeritus of Medical Microbiology and the Centre for Research in Infectious Diseases at University College Dublin’s, or UCD, School of Medicine and Medical Science. Professor Hall also serves as a consultant to the Minister of Heath and Children in the Republic of Ireland, providing input on a range of topics including influenza pandemic preparedness and bioterrorism. Prior to his tenure at UCD, Professor Hall was Professor and Head of the Laboratory of Medical Virology, Senior Physician and Director of the Clinical Research Centre at the Rockefeller University in New York. Professor Hall previously served as an Assistant and Associate Professor of Medicine at Cornell University. Professor Hall is a board member of The Atlantic Philanthropies and is a co-founder of the Global Virus Network. Professor Hall has served as a non-executive director of ICON PLC, based in Dublin, Ireland, since February 2013. Professor Hall is a member of its audit committee and the compensation committee and is chair of the nominating and governance committee. Professor Hall holds a B.Sc. (Honors) in Biochemistry and a Ph.D. in Biochemistry/Virology from Queen’s University Belfast. Professor Hall received his M.D. from Cornell University Medical College, New York and a Diploma of Tropical Medicine and Hygiene, from the London School of Hygiene and Tropical Medicine, London.
As the Independent Director of Evofem Biosciences Inc, the total compensation of William Hall at Evofem Biosciences Inc is $257,400. There are 9 executives at Evofem Biosciences Inc getting paid more, with Saundra Pelletier having the highest compensation of $2,803,980.
William Hall is 70, he's been the Independent Director of Evofem Biosciences Inc since 2018. There are 1 older and 13 younger executives at Evofem Biosciences Inc. The oldest executive at Evofem Biosciences Inc is Gillian Greer, 75, who is the Independent Director.
William's mailing address filed with the SEC is C/O EVOFEM BIOSCIENCES, INC., 12400 HIGH BLUFF DRIVE, SUITE 600, SAN DIEGO, CA, 92130.
Over the last 7 years, insiders at Evofem Biosciences Inc have traded over $32,368,585 worth of Evofem Biosciences Inc stock and bought 12,978,479 units worth $54,857,186 . The most active insiders traders include Research Corp Acacia, Fund Solutions Ltd Link, eBiopharma, Inc. Pdl. On average, Evofem Biosciences Inc executives and independent directors trade stock every 38 days with the average trade being worth of $5,281. The most recent stock trade was executed by Yan Zhang on 12 January 2024, trading 104 units of EVFM stock currently worth $4.
evofem is a biotechnology company focusing on developing innovative reproductive health products for women in every global market. evofem develops and markets products that are woman-controlled, non-invasive and rapidly reversible. women need access to effective products that are well suited to their lifestyle and consistent with their core values. products include: amphora™ - a non-hormonal vaginal gel being investigated for contraceptive and microbicidal properties.
Evofem Biosciences Inc executives and other stock owners filed with the SEC include: